Small proteins against SARS-CoV-2 neutralize infection in cell culture

Using innovative computer-based approaches, researchers have developed protein inhibitors that block the interaction between the SARS-CoV-2 virus and human cell receptor ACE2. In cell culture, the most potent of these inhibitors could neutralize virus infection, paving the way for their use in therapies that could be delivered more easily than antibodies. SARS-CoV-2 infection generally begins…

Designed antiviral proteins inhibit SARS-CoV-2 in the lab

Computer-designed small proteins have now been shown to protect lab-grown human cells from SARS-CoV-2, the coronavirus that causes COVID-19. The findings are reported today, Sept. 9, in Science In the experiments, the lead antiviral candidate, named LCB1, rivaled the best-known SARS-CoV-2 neutralizing antibodies in its protective actions. LCB1 is currently being evaluated in rodents. Coronaviruses…

Vaccine proponents and opponents are vectors of misinformation online

In a new paper published in the Harvard Kennedy School Misinformation Review, researchers from the George Washington University, University of Maryland and Johns Hopkins University assessed content from the most active vaccine-related accounts on Twitter and found that even accounts with pro-vaccination views and higher public health credibility can be vectors of misinformation in the…

ENT physicians and researchers showcase studies at Otolaryngology’s Virtual Annual Meeting

ALEXANDRIA, VA– During the AAO-HNSF 2020 Virtual Annual Meeting & OTO Experience, which runs from September 13 through October 25, the most current research in otolaryngology-head and neck surgery will be introduced during the Scientific Oral Presentations. Scientific Oral Presentations are a series of three- to six-minute presentations focusing on current evidence-based research, surgical procedures,…